EUVIMEDEUVIMED entdecken
Open Access

Benzodiazepine Use in Pregnancy and the Risk of Pregnancy Outcomes

Brian Meng-Hsun Li, Shyh-Yuh Wei, Ming-Ta Chuang, Edward Chia-Cheng Lai

JAMA Internal Medicine · 2026

DOI: 10.1001/jamainternmed.2025.6882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Internal Medicine, 2026. Verfasst von Brian Meng-Hsun Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Benzodiazepines, Pregnancy Outcome, Premature Birth. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Benzodiazepine use during pregnancy has increased despite concerns about potential risks to pregnancy outcomes, including abortion, stillbirth, preterm birth, and small for gestational age. Existing evidence remains limited by unclear clinical interpretation and methodological biases.

Objective

To evaluate the associations between benzodiazepine use and risk of preterm birth and small for gestational age while considering the risks of abortion and stillbirth as competing events. Design, Setting, and Participants Using the National Health Insurance Research Database of Taiwan from January 1, 2011, to December 31, 2021, a sequence of open-label, randomized trials during gestational weeks 0 to 36 was emulated. Eligibility criteria for each trial included pregnancy in gestational weeks 0 to 36, maternal age between 15 and 55 years, with no benzodiazepine use during the preceding 6 months. The data were analyzed from November 2024 through April 2025. Exposure Benzodiazepine use or nonuse. Main Outcomes and Measures Abortion (spontaneous abortion and elective abortion), stillbirth, preterm birth, and small for gestational age. Relative risks (RRs) were estimated across the sequence of trials. To address potential competing events (abortion or stillbirth), stabilized inverse probability of censoring weights was applied that incorporated postbaseline prognostic factors across all pregnancies. Analyses were stratified by gestational periods: first (weeks 0-13), second (weeks 14-26), and third trimester (weeks 27-36).

Results

The mean (SD) age of the individuals in the benzodiazepine group (59 521 pregnancies) and nonuse group (394 956 pregnancies) was 31.9 (5.8) and 31.6 (5.3) years, respectively. Benzodiazepine use was associated with an increased risk of abortion (RR, 1.58; 95% CI, 1.50-1.66), spontaneous abortion (RR, 1.65; 95% CI, 1.55-1.76), and elective abortion (RR, 1.83; 95% CI, 1.70-1.98) and showed no association with stillbirth (RR, 0.96; 95% CI, 0.78-1.17). After accounting for competing risks, benzodiazepine use was associated with increased risks of preterm birth (RR, 1.20; 95% CI, 1.18-1.23) and small for gestational age (RR, 1.06; 95% CI, 1.00-1.09), with more pronounced effects observed after exposure during the second trimester. Conclusions and Relevance The results of this cohort study, after considering the association of competing events, suggested that benzodiazepine use was associated with increased risks of preterm birth and may also be associated with increased risk of small for gestational age; however, the latter association was small and sensitive to the analytic method.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, SpontaneousBenzodiazepinesPregnancy OutcomePremature BirthAdolescentAdultFemaleHumansInfant, NewbornMiddle AgedPregnancyYoung AdultInfant, Small for Gestational AgeStillbirthTaiwan

Substanzen

Benzodiazepines

Autor:innen und Institutionen

  • School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Population Health Data Centre, National Cheng Kung University, Tainan, Taiwan.
  • Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Obstetrics and Gynaecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Zitieren

APA

Li, B. M., Wei, S. Y., Chuang, M. T., & Lai, E. C. (2026). Benzodiazepine Use in Pregnancy and the Risk of Pregnancy Outcomes. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.6882

Vancouver

Li BM, Wei SY, Chuang MT, Lai EC. Benzodiazepine Use in Pregnancy and the Risk of Pregnancy Outcomes. JAMA Internal Medicine. 2026. doi:10.1001/jamainternmed.2025.6882

BibTeX
@article{Li2026,
  author = {Li, Brian Meng-Hsun and Wei, Shyh-Yuh and Chuang, Ming-Ta and Lai, Edward Chia-Cheng},
  title = {Benzodiazepine Use in Pregnancy and the Risk of Pregnancy Outcomes},
  journal = {JAMA Internal Medicine},
  year = {2026},
  doi = {10.1001/jamainternmed.2025.6882}
}
Kostenlos starten →